Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-024639-18Phase 4Active
Phase 4, open-label trial of erythromycin in upper gastrointestinal bleeding (UGIB) (2 arms), sponsored by Servicio Digestivo. Primary endpoint: Identification of bleeding point. Started Nov 2011; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-024639-18.